The yeast prion-like protein Sup35 has repeats responsible for the reversible induction of an altered, but advantageous phenotype. The expansion of similar repeat domains in several mammalian proteins is associated with neurodegenerative disease -so why are these 'bungee cord' domains conserved? Address (Figure 1 ) has been made. This case relies primarily on correlations between the effects of amino acid sequence changes on in vitro protein fibrillization with the effects on the in vivo phenotype. A similar experimental approach to establishing the role of the mammalian prion protein (PrP) in scrapie has not been as successful, primarily because the in vitro conversion of PrP to the form associated with infectivity (PrP Sc ) has not been accomplished [5, 6] . Instead of assessing the effects of disease-associated mutations on PrP Sc formation, an experimentally accessible property of PrP, its thermodynamic stability, has been examined. But no correlation has been found between the pathogenicity of PrP mutations and their effect on PrP stability [7, 8] , consistent with the proposal that PrP fibrillization, rather than its unfolding, is accelerated by disease-associated mutations [9, 10] .
In 1994, Reed Wickner [1] proposed that two wellcharacterized non-Mendelian traits in yeast, known as [PSI + ] and [URE3], are inherited via a self-propagating 'protein-only' mechanism. Wickner coined the term 'yeast prion' to suggest an analogy between these phenomena and the proposed mode of transmission of mammalian scrapie by an infectious agent, or prion, comprising a single protein. The protein-only hypothesis, originally proposed to explain the unusual properties of the infectious agent, states that an abnormal form of a normal protein can propagate by somehow catalyzing the conversion of the normal form into additional copies of itself [2] . This process could be confused with viral infection in scrapie and with inheritance in yeast, both of which typically require nucleic acid [3, 4] .
In the five years since Wickner's proposal, a compelling, albeit circumstantial case for protein-only transmission of both [URE3] by the protein Ure2p and [PSI+] by Sup35 (Figure 1 ) has been made. This case relies primarily on correlations between the effects of amino acid sequence changes on in vitro protein fibrillization with the effects on the in vivo phenotype. A similar experimental approach to establishing the role of the mammalian prion protein (PrP) in scrapie has not been as successful, primarily because the in vitro conversion of PrP to the form associated with infectivity (PrP Sc ) has not been accomplished [5, 6] . Instead of assessing the effects of disease-associated mutations on PrP Sc formation, an experimentally accessible property of PrP, its thermodynamic stability, has been examined. But no correlation has been found between the pathogenicity of PrP mutations and their effect on PrP stability [7, 8] , consistent with the proposal that PrP fibrillization, rather than its unfolding, is accelerated by disease-associated mutations [9, 10] .
One class of disease-associated insertional mutations of PrP affect its normally unstructured amino-terminal region, which contains five copies of a conserved octapeptide repeat ( Figure 2 ) [11] . Families have been identified in which insertion of additional copies of the repeat causes disease. Lindquist and Liu [12] recently noticed a similarity between the PrP octapeptide repeat and a nonapeptide sequence that is repeated five times in Sup35, within an amino-terminal domain known to be critical for its in vitro fibrillization and for induction of the associated [PSI + ] phenotype (Figure 2 ). They went on to test whether the Sup35 repeats mediate oligomerization and/or fibrillization by producing two sequence variants of Sup35, one in which two repeats were added, and the other in which four repeats were removed.
Lindquist and Liu [12] found that the expanded Sup35 (Exp-Sup35 in Figure 1 ) promoted conversion of yeast to the [PSI + ] phenotype, whereas the truncated protein precluded appearance of the phenotype. Furthermore, recombinant peptides based on the portion of the Sup35 sequence containing one, five or seven repeats were shown to form amyloid fibrils at rates that paralleled the in vivo phenotypes; that is, the expanded peptide fibrillized most rapidly and the truncated peptide most slowly. These rate differences were observed starting with chemically denatured substrates, suggesting that the promotion of Sup35 fibrillization, rather than facilitation of Sup35 unfolding, is the mechanism whereby some or all of the insertional mutations exert their effects. The authors suggest that this may also be the case for the PrP insertion mutations, as well as other PrP mutations associated with prion diseases [12] .
A different approach to identifying the sequence within Sup35 that promotes the [PSI + ] phenotype was taken by Weissman and coworkers [13] and inspired an analogy between the yeast prion-like elements and the 'triplet repeat' class of neurodegenerative diseases, of which Huntington's disease is perhaps the most notorious. A Sup35 fragment was randomly mutagenized and yeast colonies were then screened for loss of the preexisting [PSI + ] phenotype, or gain of the alternative phenotype. Forty-one mutant sequences were determined, each of which was found to contain point mutations in the region between residues 8 and 24 at the extreme amino-terminus of Sup35 (Figure 2 ).
This region of Sup35 contains two of the nonapeptide repeats discussed above. Thirty-four of the 41 mutations involved changes of asparagine or glutamine residues, primarily (32 out of the 34 cases) to charged amino acids. Six of these mutations were introduced into a fibrillogenic Sup35 fragment; four decreased the rate of its fibrillogenesis, while the other two had no significant effect. Weissman and colleagues [13] proposed that it is the high local concentration of glutamine and asparagine residues -distinguished by their amide side chains, which can promote unusual structures [14] -that drives fibrillization of the amino-terminal region of Sup35. Furthermore, they suggested an analogy between the aggregation Sup35 and that of huntingtin (Htn), which is promoted by an expansion of a preexisting polyglutamine tract that is associated with Huntington's disease ( Figure 1 ) [15] . To emphasize this analogy, a construct in which the entire Sup35(8-24) sequence was replaced by glutamine residues was shown to form insoluble aggregates in yeast, similar to those formed by wild-type Sup 35 in [PSI + ] yeast [13] .
Huntington's disease is caused by an expansion of a preexisting tract of glutamine residues in Htn from the normal range of 6-35 residues to anywhere between 36 and 121 glutamine residues [15] . The length of the expansion is correlated to the age of onset and severity of symptoms, with particularly long polyglutamine tracts causing juvenile-onset disease. Recombinant peptides based on the disease-associated expanded polyglutamine tract, form amyloid fibrils in vitro that resemble those found in neuronal intranuclear inclusions characteristic of the Huntington's disease brain [16] . The rate of in vitro amyloid formation depends on the length of the polyglutamine tract, supporting a correlation between fibril formation and disease and suggesting that the Htn fibril, or an oligomeric species whose formation is linked to that of the fibril, may be pathogenic in Huntington's disease. The Sup35/PrP/Htn analogy is imperfect, however, as there is no evidence that Huntington's disease can be transmitted by Htn fibrils, though seeding of in vitro fibril formation by preformed model peptide fibrils does occur [16] .
Lindquist [3] has suggested that the fibrillization of Sup35 may provide a useful adaptive mechanism to change gene expression patterns in response to rapid environmental changes. In that capacity, it would be important for the [psi -] to [PSI + ] 'switch' to be reversible, in the event of a return to the original conditions ( Figure 1 ). Fibrillization of Sup35 may thus have been 'adjusted' by evolution to achieve optimal rates in the forward and reverse directions. Inclusion of seven nonapeptide repeats, rather than five, may slow down the back reaction to the extent that spontaneous loss of the [PSI + ] phenotype would be too slow, whereas inclusion of only two repeats may slow down the forward reaction to the extent that spontaneous acquisition of the [PSI + ] phenotype would not occur often enough to provide an evolutionary advantage.
Given the possibility of fibrillization, why do the proteins involved in neurodegenerative diseases also contain R846 Current Biology Vol 9 No 22
Figure 2
The yeast prion-like protein Sup35 and two other proteins that contain repeating sequences (red) and are involved in neurodegenerative diseases. Huntingtin (Htn) is one representative of a large class of proteins that contain expandable polyglutamine tracts [15] . (Q) Sup35 PrP
Htn

Figure 3
A mechanistic proposal to explain the persistence of expandable repeat sequences ('bungee cord' domains) in proteins involved in neurodegenerative diseases. According to this scenario, the normal function of these proteins may depend on the repeat sequence, creating an evolutionary rationale for retaining sequences that, when expanded, promote fibrillization.
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Wild-type Insertional mutant expandable repeat domains that put the protein 'at risk' of pathogenic insertional mutation? One possible explanation is that these conserved repeats may be important for the normal, as yet unknown, functions of these proteins. The length of the normal repeat domain may be a compromise between optimization of that function and minimization of early-onset disease (Figure 3 ). The repeat domains may directly mediate functional oligomerization, as appears to be the case with Sup35 and Htn, or may do so indirectly (Figure 3 ). This would explain why evolution has not eliminated an existing mechanism for polyglutamine expansion by which repeat lengths can increase -and the associated disease appear earlier -in successive generations. This phenomenon, known as anticipation, may be the pathogenic consequence of an adaptive mechanism that allows the function-dysfunction balance point to be reset after rapid environmental change.
I propose the term 'bungee cord domains' to describe these sequences, as the selection of an ideal bungee cord is based on its length and involves a compromise between the intended function of the jump (presumably the thrill of a close call) with a desire to minimize the risk of death (the risk of injury, like that of late-onset disease, may be tolerated). In addition to PrP and the polyglutamine-containing proteins, the Parkinson's disease-related protein α-synuclein [17] , which contains six copies of an undecapeptide repeat that has been implicated in membrane binding, and the Alzheimer's disease-related protein tau, which contains three or four repeats that are involved in microtubule binding, may belong in this class. As the normal functions of these proteins are elucidated and their bioactive oligomerization states are determined, the bungee cord proposal will be put to the test. One critical consequence of this proposal -that inhibition of pathogenic fibrillization may also inhibit a critical normal function -should be noted by those interested in development of therapeutic strategies against neurodegenerative diseases.
